DAVID GRANOVSKY

Embryonic Stem Cell Alternative Has Another Advance, IPS Cells Yield Nerve Cells

In ALL ARTICLES, STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on February 26, 2009 at 5:02 pm
ipsc-neural-stem-cells

ipsc-neural-stem-cells

This is great, but adult stem cells are still the best chance for someone with a debilitating or deadly disease to get a therapeutically beneficial treatment NOW! – DG

by Steven Ertelt -LifeNews.com Editor -February 25, 2009

Los Angeles, CA (LifeNews.com) — One of the alternatives to the use of embryonic stem cells has made another advance and, this time, induced pluripotent stem cells, or iPS cells, have yielded nerve cells. Researchers made a type of nerve cells from the iPS cells, which are embryonic-like cells reverted from their adult state.

The cells are hailed by pro-life groups as an ethical alternative to the use of embryonic stem cells, which can only be obtained by destroying human life.

A team at the University of California Los Angeles was able to make motor neurons out of the induced pluripotent stem cells and the scientists hope to make cells tailored to specific diseases for therapy.

BY converting the iPS cells into motor neurone cells, scientists may be able to better treat amyotrophic lateral sclerosis, or ALS.

“IPS-derived cells appeared to follow a normal developmental progression associated with motor neuron formation,” they wrote in the journal Stem Cells.

The researchers added that the new cells they created look just like embryonic stem cells, yet they didn’t have to destroy days-old human embryos, or unique human beings, to get them.

The researchers at UCLA plan to attach the new cells to muscle cells to determine if they will contract and they hope to eventually be able to take a skin cell sample from a patient to generate a tissue transplant or build a stem cell bank for other patients.

Adult stem cells have also been helpful in dealing with ALS.

Last year, a unique pilot study established a safe pathway for using bone-marrow stem cells to slow down and potentially treat Lou Gehrig’s disease.

Dr. Neil Cashman, professor of neurology at the University of British Columbia and director of the ALS program at Vancouver Coastal Health and VCH Research Institute, headed the study.

He published the results in the medical journal Muscle & Nerve and he and his colleagues tested the use of a growth factor stimulant in ALS patients and found that bone-marrow stem cells became activated with no adverse effects to patients.

“Our idea was to use a growth factor stimulant to increase the number of circulating stem cells from within the body’s bone marrow where they would have the potential to travel to the site of injury and begin repair, slowing down the progression of ALS,” he said.

via Embryonic Stem Cell Alternative Has Another Advance, IPS Cells Yield Nerve Cells.

About these ads

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 3,080 other followers

%d bloggers like this: